Trial intelligence / Profile preview

Modafinil for Hypoactive Delirium in ICU

NCT02028260Phase 3Withdrawn

Sponsor
Brigham and Women's Hospital
Start
Jan 2014
Primary completion
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of modafinil in delirium, sponsored by Brigham and Women's Hospital. Planned start Jan 2014; status: withdrawn.

02

Drugs

modafinil
03

Conditions

delirium

Beyond the preview

Go deeper on NCT02028260.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02028260.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call